Maze Therapeutics (NASDAQ:MAZE) shares were trading largely flat following a $140M initial public offering. Shares of the kidney disease drug developer opened at $16 per share after being priced ...
Small 500- to 1000-size reels with 4-pound-test line matched with a 6-foot ultralight ... Remember how awesome the crappie fishing was during the spring? The fish were spawning, bunched in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback